These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 21867409)

  • 1. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.
    She ZG; Chen HZ; Yan Y; Li H; Liu DP
    Antioxid Redox Signal; 2012 Mar; 16(6):597-632. PubMed ID: 21867409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase and atherosclerosis-related cardiovascular diseases.
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.
    Wysocka A; Zwolak A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
    Taler-Verčič A; Goličnik M; Bavec A
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33348669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common mutation in paraoxonase-2 results in impaired lactonase activity.
    Stoltz DA; Ozer EA; Recker TJ; Estin M; Yang X; Shih DM; Lusis AJ; Zabner J
    J Biol Chem; 2009 Dec; 284(51):35564-71. PubMed ID: 19840942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonases-1, -2 and -3: What are their functions?
    Furlong CE; Marsillach J; Jarvik GP; Costa LG
    Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.
    Harel M; Aharoni A; Gaidukov L; Brumshtein B; Khersonsky O; Meged R; Dvir H; Ravelli RB; McCarthy A; Toker L; Silman I; Sussman JL; Tawfik DS
    Nat Struct Mol Biol; 2004 May; 11(5):412-9. PubMed ID: 15098021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body].
    Borovkova EI; Antipova NV; Komeenko TV; Shakhparonov MI; Borovkov IM
    Vestn Ross Akad Med Nauk; 2017; 72(1):5-10. PubMed ID: 29308836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, infection, cancer and all that…the role of paraoxonases.
    Devarajan A; Shih D; Reddy ST
    Adv Exp Med Biol; 2014; 824():33-41. PubMed ID: 25038992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paraoxonase 1, 2 and 3 in humans.
    Rajkovic MG; Rumora L; Barisic K
    Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
    Draganov DI; Stetson PL; Watson CE; Billecke SS; La Du BN
    J Biol Chem; 2000 Oct; 275(43):33435-42. PubMed ID: 10931838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.
    Farid AS; Horii Y
    Lipids Health Dis; 2012 Jul; 11():92. PubMed ID: 22824324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.
    Otocka-Kmiecik A; Orłowska-Majdak M
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():668-77. PubMed ID: 20097953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of biologically active δ-lactone eicosanoids as paraoxonase substrates.
    Teiber JF; Xiao J; Kramer GL; Ogawa S; Ebner C; Wolleb H; Carreira EM; Shih DM; Haley RW
    Biochem Biophys Res Commun; 2018 Oct; 505(1):87-92. PubMed ID: 30241945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactonases with organophosphatase activity: structural and evolutionary perspectives.
    Draganov DI
    Chem Biol Interact; 2010 Sep; 187(1-3):370-2. PubMed ID: 20122908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of paraoxonase in cancer.
    Bacchetti T; Ferretti G; Sahebkar A
    Semin Cancer Biol; 2019 Jun; 56():72-86. PubMed ID: 29170064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three-gene paraoxonase family: physiologic roles, actions and regulation.
    Précourt LP; Amre D; Denis MC; Lavoie JC; Delvin E; Seidman E; Levy E
    Atherosclerosis; 2011 Jan; 214(1):20-36. PubMed ID: 20934178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.
    Dasgupta S; Demirci FY; Dressen AS; Kao AH; Rhew EY; Ramsey-Goldman R; Manzi S; Kammerer CM; Kamboh MI
    BMC Med Genet; 2011 Jan; 12():7. PubMed ID: 21223581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
    Ng CJ; Bourquard N; Grijalva V; Hama S; Shih DM; Navab M; Fogelman AM; Lusis AJ; Young S; Reddy ST
    J Biol Chem; 2006 Oct; 281(40):29491-500. PubMed ID: 16891303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.